Other operating income (excl. revaluation income and releases from provisions) and financial income from operating receivables
26, 27
9,666,292
6,542,519
4.
Net claims payments in the period
28
-76,192,344
-77,542,688
5.
Expenses for bonuses and rebates
29
-811
85,678
6.
Net operating expenses excl. depreciation/amortisation and change in deferred acquisition costs
30
-47,125,714
-43,573,077
7.
Investment expenses (excluding amortisation and financial expenses)
25
0
-422
8.
Other operating expenses excl. depreciation/amortisation (other than for revaluation and excl. additions to provisions)
32
-5,941,686
-6,024,419
9.
Tax on profit and other taxes not included in operating expenses
33
-3,154,368
-1,789,671
b)
Changes in net operating assets (receivables for premium, other receivables, other assets and deferred tax assets/liabilities) of operating items of the statement of financial position
-4,866,086
3,625,406
1.
Change in receivables from primary insurance
8
2,649,187
-85,167,822
2.
Change in receivables from reinsurance
8
-1,639,353
76,400,625
4.
Change in other receivables and other assets
8
182,632
-248,958
5.
Change in deferred tax assets
3
-628,544
134,610
7.
Change in liabilities arising out of primary insurance
20
-7,120,985
51,160,115
6.
Change in liabilities arising out of reinsurance business
20
59,386
-40,633,836
7.
Change in other operating liabilities
21
882,308
2,168,441
8.
Change in other liabilities (except unearned premiums)
21
749,283
-187,768
c)
Net cash from/used in operating activities (a + b)
5,619,383
15,645,938
B.
Cash flows from investing activities
a)
Cash receipts from investing activities
998,709,965
762,460,219
1.
Interest received from investing activities
26
3,589,693
3,895,945
2.
Cash receipts from dividends and participation in the profit of others
26
34,234,600
26,755,664
4.
Proceeds from sale of property, plant and equipment
12,319
9,879
5.
Proceeds from sale of financial investments
960,873,353
731,798,731
b)
Cash disbursements in investing activities
-987,958,197
-740,531,828
1.
Purchase of intangible assets
-326,455
-269,153
2.
Purchase of property, plant and equipment
-396,476
-208,526
3.
Purchase of financial investments
-987,235,267
-740,054,149
c)
Net cash from/used in investing activities (a + b)
10,751,768
21,928,391
C.
Cash flows from financing activities
b)
Cash disbursements in financing activities
-12,398,157
-38,885,691
1.
Interest paid
0
-718,338
3.
Repayment of long-term financial liabilities
0
-24,000,000
4.
Repayment of short-term financial liabilities
0
-1,769,196
5.
Dividends and other profit participations paid
-12,398,157
-12,398,157
c)
Net cash from/used in financing activities (a + b)
-12,398,157
-38,885,691
D
Closing balance of cash and cash equivalents
10,651,452
6,678,458
x)
Net increase/decrease in cash and cash equivalents for the period (Ac + Bc + Cc)
3,972,994
-1,311,361
y)
Opening balance of cash and cash equivalents
6,678,458
7,989,819
The notes to the financial statements in sections 23.2–23.10 form an integral part of these financial statements.
